Apyx Medical Corp
NASDAQ:APYX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Apyx Medical Corp
Total Current Liabilities
Apyx Medical Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Apyx Medical Corp
NASDAQ:APYX
|
Total Current Liabilities
$11.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Current Liabilities
$5.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Current Liabilities
$1.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Current Liabilities
$7.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Current Liabilities
$16.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Current Liabilities
$2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
Apyx Medical Corp
Glance View
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 272 full-time employees. The firm operates through two segments: Advanced Energy and original equipment manufacturer (OEM). Its Advanced Energy product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. These product lines consist of a multifunction generator, a handpiece, and a supply of helium gas. Its primary focus is on the cosmetic surgery market, where Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. The firm designs, develops, and manufactures electrosurgical equipment by producing generators and related accessories for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for its energy-based designs.
See Also
What is Apyx Medical Corp's Total Current Liabilities?
Total Current Liabilities
11.7m
USD
Based on the financial report for Dec 31, 2025, Apyx Medical Corp's Total Current Liabilities amounts to 11.7m USD.
What is Apyx Medical Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
11%
Over the last year, the Total Current Liabilities growth was 9%. The average annual Total Current Liabilities growth rates for Apyx Medical Corp have been -1% over the past three years , 5% over the past five years , and 11% over the past ten years .
